I
Ipsen is a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and neuroscience.
Mundipharma is a global pharmaceutical company with over 60 years of heritage, offering around 50 medicines across pain management, oncology, respiratory, and infectious disease.
Mundipharma is a global healthcare company with over 60 years of heritage, focused on developing and delivering treatments across Pain Management, Oncology, Respiratory, and Infectious Disease. Its portfolio comprises approximately 50 primary and specialty care medicines.
The company operates across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East. Mundipharma's stated culture emphasises integrity, patient-centricity, continuous learning, and a collaborative environment.